Sunday 01 Sep, 2024 02:42 PM
Site map | Locate Us | Login
   NBCC board approves 1:2 bonus issue    LIC pares stake in HDFC AMC    Indian Hume Pipe bags order worth Rs 859 cr    GPT Infra emerges as L-1 bidder for Rs 204-cr order    Emami to acquire remaining 49.6% stake in The Man Company    Anup Engg inks pact with Graham to expand manufacturing and supply capabilities    Centum Electronics bags Rs 108-cr order from DRDO    Hazoor Multi Projects bags orders worth Rs 70 cr    CRISIL reaffirms rating of Kalpataru Projects; maintains 'stable' outlook    Insecticides (India) board OKs proposal to buyback 5 lakh shares through 'tender' route    Adani Ports and SEZ to buy 80% stake in Astro Offshore for $185 mln    HAL gains on inking pact with SAFHAL to develop next-gen helicopter engines    Zydus Life Jarod facility receives USFDA warning letter    Jai Corp Ltd leads losers in 'A' group    Inventure Growth & Securities Ltd leads losers in 'B' group 
Saravan Stocks
       
Company News
Divis Laboratories Ltd
Divis Lab Q1 PAT climbs 21% YoY to Rs 430 cr
Aug 03,2024   Hrs IST

Revenue from operations grew by 19.12% year on year to Rs 2,118 crore in the quarter ended 30 June 2024.

Profit before tax for the quarter was at Rs 604 crore, up 22.76% from Rs 492 crore reported in the same period a year ago.

Total expense stood at Rs 1593 crore in Q1 FY25, up 16.53% on YoY basis. Cost of material consumed was at Rs 893 crore (up 7.72% YoY) and employee benefit expenses stood at Rs 292 crore (up 11.03% YoY) during the period under review.

Forex loss for the current quarter amounted to Rs 1 crore as against a gain of Rs 3 crore posted in Q1 FY24.

On standalone basis, the company’s net profit surged 24.64% to Rs 430 crore on 19.25% rise in revenue to Rs 2,063 crore in Q1 FY25 over Q1 FY24.

Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.

Shares of Divis Laboratories gained 1.40% to end at Rs 4,990.35 on Friday, 2 August 2024.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 35075411
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd